BioReference Laboratories Inc. is the largest independent regional clinical laboratory in the Northeast & has major market positions in physician offices nursing homes & correctional institutions. The Company is a full service clinical laboratory with specialty capability especially in the areas of genomics oncology correctional health & complimentary medicine. PSIMedica a business unit of the Company is a clinical knowledge management organization offering an array of information solutions for reducing healthcare costs & improving quality performance that are based on a flexible scalable software analytical engine that utilizes all available source information including claims data enrollment data prescription data & laboratory data. They provides a comprehensive connectivity solution to physicians as well as other laboratories which includes laboratory reporting & ordering as well as laboratory to physician communications & cumulative reporting through CareEvolve its Bioreference Laboratories Inc. has a market cap of $479.6 million; its shares were traded at around $34.68 with a P/E ratio of 25.5 and P/S ratio of 1.6. Bioreference Laboratories Inc. had an annual average earning growth of 19.8% over the past 5 years.
Recent Trades of BioReference Laboratories Inc. by CEO:
- Sell: President, CEO, 10% Owner Marc Grodman sold 35,000 shares of BRLI stock on 07/09/2009 at the average price of $30.37; the price of the stock has increased by 14.19% since.
Recent Trades of BioReference Laboratories Inc. by CFO:
- Sell: Sr. VP, Sec'y, Treasurer, CFO Sam Singer sold 4,300 shares of BRLI stock on 09/04/2009 at the average price of $34.76; the price of the stock has decreased by 0.23% since.
- Sell: Sr. VP, Sec'y, Treasurer, CFO Sam Singer sold 16,500 more shares of BRLI stock on 07/14/2009 at the average price of $30; the price of the stock has increased by 15.6% since.
- Sell: Sr. VP, Sec'y, Treasurer, CFO Sam Singer sold 16,000 more shares of BRLI stock on 06/08/2009 at the average price of $30.47; the price of the stock has increased by 13.82% since.
Recent Trades of BioReference Laboratories Inc. by Directors and Officers:
- Sell: Director Gary Lederman sold 12,000 shares of BRLI stock on 10/05/2009 at the average price of $35.24; the price of the stock has decreased by 1.59% since.
Become a Premium Member to See This: (Free Trial):
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
Rate This Article: |
  |